2don MSN
One Pre-Pregnancy Blood Test That Can Reveal Your Risk for Complications, According to a New Study
And when they controlled for a handful of variables (like age and health conditions), they found that the women with the ...
BabyCenter on MSN
Why you need to pee all the time during pregnancy (and what helps)
Frequent urination can be a sign of a urinary tract infection (UTI), the most common kind of bacterial infection in pregnant ...
The Takeout on MSN
Dip Recalls That Affected Millions
While they're great snacks, dips from various brands are often recalled for consumer safety, including favorites like hummus, ...
Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will be exclusively available through ...
Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...
What to Expect on MSN
Here’s Why Snoring During Pregnancy Happens (And How to Quiet It Down)
Are your sudden nighttime noises disrupting your sleep? Here's why you're snoring during pregnancy and what you can do.
Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 ...
About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as ...
(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...
First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line ...
Highlights include clinical data from Phase 3 studies in Community Acquired Pneumonia (CABP) and microbiologic data from a Phase 2 study in nontuberculous mycobacterial pulmonary disease (NTM-PD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results